Package 51407-703-06

{"route": ["ORAL"], "spl_id": "4c9db5a6-88e7-5f5a-e063-6294a90acb0e", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "upc": ["0351407703064", "0351407704030", "0351407702067", "0351407701053"], "unii": ["1NF15YR6UY"], "spl_set_id": ["377c3ecb-fdec-dde4-e063-6294a90a29bd"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (51407-703-06)  / 1 CAPSULE in 1 BLISTER PACK (51407-703-66)", "package_ndc": "51407-703-06", "marketing_start_date": "20250611"}], "brand_name": "APREPITANT", "product_id": "51407-703_4c9db5a6-88e7-5f5a-e063-6294a90acb0e", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "51407-703", "generic_name": "APREPITANT", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "APREPITANT", "active_ingredients": [{"name": "APREPITANT", "strength": "125 mg/1"}], "application_number": "ANDA211835", "marketing_category": "ANDA", "marketing_start_date": "20201021", "listing_expiration_date": "20271231"}